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A peroxidase-antiperoxidase study using monoclonal 
antibodies directed against T and B lymphocytes and 
Langerhans cells/indeterminate cells (LC/IC) was un-
dertaken in order to understand more clearly the 
changes observed in erythema multiforme. At the var-
ious stages of development, from normal skin to target 
lesions, the quantity of inflammatory cells differed, but 
in each case the number of TS+ (cytotoxic/suppressor) 
cells was greater than the number of T4+ (helper/indu-
cer) cells in the epidermis, whereas the latter exceeded 
the former in the dermis. Concomitant with the initial 
epidermal changes, there was an increase in the number 
of T6+ (LC/IC) cells in the upper and lower epidermis. 
With slight to moderate basal unit destruction, the num-
ber of LC/IC in the upper epidermis exceeded those in 
the lower epidermis. With severe basal unit destruction, 
there was a loss of LC/IC in the lower epidermis as 
detected by T6 reactivity. In fully formed blisters, the 
LC/IC in the upper half of the epidermis were decreased 
in parallel with the degree of epidermal necrosis. 
The character of the lymphocytic inflammatory infil-
trate and redistribution in LC/IC are similar to those 
findings described in allergic contact dermatitis. The 
clinical, histologic, and immunopathologic changes in 
erythema multi forme appear to be due in part to cellular 
immune mechanisms with the lymphocyte as the pre-
dominant effector cell, and our data suggest a possible 
role for LC/IC in this disorder. 
A role for immune complexes in the pathogenesis of erythema 
multiforme has been proposed owing to the detection of C3, 
either alone or with IgM, in t he superficial cutaneous micro-
vasculature as well as at the derma l-epidermal junction in 
les ions less t han 24 hold [1- 7]. Immune complexes have a lso 
been detected in the blister fluid and in sera in patients with 
recurrent erythema multiforme [3-7]. 
In lesions at various stages of developmen t, the ini t ia l 
cha nges occu rred in t he superficia l microvasculature in associ-
ation with a scan t perivenu lar mononuclea r cell infilt rate [1] . 
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With evolut ion to t he characteristic target lesion, t he infla m -
matory infiltrate was composed of increased numbers of trans-
formed lymphocytes a nd macrophages with partially degranu -
lated basophils and mast cells [1] . The character of t he infiltrate 
a nd morphologic changes observed in evolving lesions of ery-
t hema multiforme were distinctly different fro m other disorders 
mediated by complemen t-fixing immune complexes in which 
a n infiltrate of neutrop hils is associated with necrotizing ven -
uliti s [8, 9] . 
To cha racterize furt her the types of inflammatory cells at 
various stages of les ion development, biopsy specimens from 3 
patients with recurrent erythema multiforme were studied by 
peroxidase-antiperoxidase (PAP) labeling of cells us ing mon o-
clonal antibodies directed against lymp hocytes a nd Langer hans 
cells/indeterminate cell s (LC/ IC). 
MATERIALS AND METHODS 
T hree subjects enrolled in t he study after giving informed consent. 
Each indi vidual had an acute self-limited cutaneous erupt ion with at 
least 1 target lesion cha racteristic of erythema multi forme. No subject 
had received eit her systemic or topical cort icosteroid t herapy fo r 2- 3 
months prior to t he study. In each case, lesions evolved throuuh 3 
clinical stage : an erythematous papule, a vesicle surmounti n; an 
erythematous papule, and a ta rget lesion [1] . 
A 4- mm skin treph ine biopsy specimen was obtained from lesions at 
each clinical stage and from clinically uninvolved skin more than 2-3 
em from the nearest lesion. Loca l anesthesia was accomplished by 
InJeCtiOn around the periphery of the biopsy site with 2% lidocaine 
without epinephrine. 
One half of each specimen was immediate ly fixed in a solution 
containing 2.5% glutaraldehyde, 2% paraformaldehyde, and 0.025% 
calcium chloride in 0.1 M cacodylate buffer, pH 7.4; postfixed in 1% or 
2% osmium tetrox ide; dehydrated; and embedded in Epon. Sections 
1-J.Lm thick were stained with alkaline Giemsa reauent and examined 
by light microscopy at magnifications up to 1000x [S,10- 13]. The other 
half of each specimen was immediate ly frozen in OCT compound (Ames 
Co., Division of Miles Laborato ries, Elkhart, Indiana) and stored at 
-70'C. Four-micrometer t hick cryostat sections were stained by a 4-
step immunoperox idase technique using PAP complexes. The frozen 
tissue sections were overlayed with 25 11! of a 1:500 dilu tion of murine 
ascitic fluid conta ining eit her anti-T4, anti -T48, anti-T8, anti -T6, 
anti-11 , or ant i-IgM antibodies (14- 23] (Table I) and incubated for 60 
min in moist chambers at room temperature. Sections were sequentially 
incubated with a 1:40 dilution of rabbi t ant imouse ant iserum (N. L. 
Cappel Laboratories, Inc., Coc hranville, Pennsylvania) , a 1:40 dilut ion 
of swine anti rabbit antiserum , and a 1:50 dilution of peroxidase rabbit 
antiperox idase reagent (Dako Immunoglobulins, Copenhagen, Den-
mark) for 20-30 min each. The sections were rinsed with phosphate-
buffered saline (PBS) between incubations. Sections were ta ined with 
3'3' -diaminobenzidine (Sigma, St. Louis, Missouri) for 30-, 60-, 90-, 
and 120-s intervals , rinsed in PBS to terminate t he stainin" reaction 
and then examined by light microscopy [22]. b ' 
In the evaluation of LC/IC, t he number and distribu t ion of these 
cells per linear millimeter of epidermis were quantitated and plotted 
against t he histologic degree of basal uni t destruction dell ned as slight, 
moderate, severe, and severe wi th blister formation. In order to insure 
uniformity in t he counting of dendritic T6+ cells, only t hose wi th a 
nucleus visible as "negative staining" were counted. 
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TABLE I. Reactivity of monoclonal antibodies used in the evaluation of 
lymphocytes and Langerhans cells/indeterminate cells (LC/IC) 
Mo noclonal 
a ntibody" 
Anti-T4 (0KT4) 
Ant i-T4B 
Anti-T8 (0KT8) 
Anti-T6 (OKT6) 
Anti -ll (OKil) 
Anti-lgM 
Reactiv ity 
Helper/ inducer T cells 
(60% of ci rculating T cells) 
Cytotoxic/suppressor T cells 
(20- 30% of circulating T cells) 
LC/IC 
(cort ical t hymocytes) 
Activated T cells 
B cells 
Monocytes/macrophages 
Langer hans cells 
Endothelial cells 
(!a- like (HLA-DR) ant igens) 
lgM+ B cells 
" The OK series of monoclonal ant ibodies were obta ined from Ortho 
P harmaceut ical, Rari tan, New J ersey. Ant i-T4B antibody was kindly 
donated by Dr. E llis Reinherz and anti-IgM ant ibody by Dr. Lee Nadler, 
Dana-Farber Cancer Institute, Boston, Massachusetts. 
RESULTS 
T and B Lymphocytes 
Evaluation of lymphocytes wit h ant i-T4, ant i-T 4B, and ant i-
TS monoclonal ant ibodies showed that the absolute number of 
T cells increased as the lesions evolved. In a ll stages, the 
epidermis contained more T 8+ cells t han T4+ cells. However, 
in the superficial and deep dermis, the majority of the infiltrate 
consisted of T 4+ cells. Few or no lgM-posit ive B lymphocytes 
were detected in t he dermal infilt rate or in the epidermis. 
Langer hans Cells/Indeterminate Cells 
In the init ial evaluation of LC/IC, as stained by ant i-T6 and 
ant i-Il ant ibodies, it was noted t hat the number and distribu-
t ion of these cells did not parallel t he clinical stages of evolving 
lesions. Instead, the number of LC/IC in the upper and lower 
port ions of the epidermis varied with t he degree of epidermal 
basal uni t destruction. In each lesion, diffe rent degrees of basal 
unit destruction were present in different areas. In the epider-
mis overlaying t he vesicle on an erythematous papule there was 
severe basal unit destruction which diminished in severity 
peripherally (Fig 1). 
T he total number of LC/IC in t he epidermis increased 
through moderate to severe basal unit destruction. Also, their 
cell bodies were larger and their dendri tes were more promi-
nent . In t he lower half of the epidermis, an init ial increase in 
t he number of LC/IC preceded a decline wit h t he onset of slight 
to moderate basal unit destruction (Fig 2). In t he upper half of 
the epidermis, LC/IC increased as basal unit destruction be-
came moderate to severe. In t he 1 case in which there was 
suffic ient t issue to study t he blister roof, t he LC/IC in the 
upper half of the epidermis were the most numerous when 
moderate basal uni t destruction was observed. Beyond t hat , t he 
num ber in the blister roof progressively decreased in parallel 
wit h t he degree of epidermal necrosis (Figs 3, 4). In the dermis, 
only a few T6+ cells were noted in each specimen. In each case, 
the number of dendrit ic 11 + cells in the epidermis was less 
than the number of T6+ cells, but the changes in their distri -
but ion were similar. 
DISCUSSION 
In this study, PAP staining of cells wit h monoclonal ant i-
bodies was used to define the nature of the inf1ammatory 
in fi lt rate and the changes in LC/IC in erythema mult iforme. 
T here were 2 major observations. Firstly, T lymphocytes were 
the major in fil trating cells with T8+ cells in fil t rating the epi-
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dermis out of proport ion to their numbers in t he dermal in fil-
t rate. Secondly, LC/IC were not detected in zones of extensive 
basal unit destruction in the roof of the blister . 
In t he sequent ial observation of histologic sections from 
uninvolved skin to target lesions, it was obse rved t hat t he T 8+ 
(cytotoxic/suppressor) cells exceeded t he number of T4+ 
(helper/ inducer) cells in the epidermis and that the reverse was 
F IG 1. Vesicle surmounting an erythematous papule wit h slight (6), 
moderate ("'), and severe (0 ) basal unit destruction and blister (+ ) 
(1-!.tm Epon-embedded Giemsa-sta ined section, X 400) . 
LAHGERHANS 
CEt~~AR ~ 
OF 
EP I DERH I S _____ .. 
SLIGHT ~DERATE 
DEGR([ Of BASAl UNIT DESTRUCTION 
,_., 
SEVERE BLISTER 
F IG 2. Changes in the number of Langerhans cells in the lower half 
of the epidermis in each of 3 cases (R, G, D) . 
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NORHAL SL IGHT fo'OOERATE SEVtRE BLISH A 
DEGREE OF BASAL UNIT DESTRUCTION 
F IG 3. Changes in the number of Langerhans cells in the upper half 
of t he epidermis in eac h of 3 cases (R, G, D). 
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FIG 4. PAP staining of Langerhans cells in the epidermis. A, LC/IC limited to t he lower half of the epidermis in an area of slight basal unit 
destruction. B, LC/ IC in the upper and lower half of the epidermis in an area of slight to moderate basa l unit destruction. C, LC/ IC in the upper 
half of the epidermis in an area of severe basal unit destruction. D, Roof of a bulla with a decreased number of LC/IC in the epidermis (A - D: 
anti -T6 monoclonal antibody, X 400) . 
true in the dermis. Very few cells in the dermal infiltrate had 
surface IgM as found on B lymphocytes. A similar distribution 
of inflammatory cells has been seen in human skin allograft 
rejection [22) . In this disorder as well as in chronic graft-vs-
host disease and advanced lesions of pityriasis lichenoides et 
varioliformis acuta (PLEVA), the predominant cells in the 
epidermis are cells with cytotoxic/suppressor phenotype (T8+ ). 
In each disorder, a cellular immune mechanism has been im-
plicated in the pathogenesis of the disease [22, 24,t]. 
The number and distribution of T6+ cells (LC/IC) m the 
1" Muhlbauer JE, Bhan AK, Harrist TJ , Moscicki RA, Rand R, 
Caughman W, Loss B, Mihm MC Jr: Immunopathology of pityriasis 
lichenoides acuta. (Submitted for publication.) 
epidermis was altered in parallel with the other epidermal 
changes. In early lesions, intraepidermal LC/ IC increased in 
apparent size and number as compared to those in normal skin. 
Furthermore, there was a redistribution of LC/IC to a higher 
level in the epidermis with the onset of intra- and intercellular 
edema and necrosis. This finding has been previously observed 
not on ly in experimentally induced lesions of allergic contact 
dermatitis in guinea pigs but also in PLEVA in humans 
[25,t). As the epidermal changes become more extensive, the 
LC/ IC disappeared from the area of epidermal destruction. 
Possible explanations include cell death, migration, lack of 
reactivity due to the cellular milieu, loss of T6 and I1 antigens, 
or shedding with the parakeratotic stratum corneum [25,t]. 
In guinea pigs and humans, LC/IC are associated with lym-
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phocytes at sites of allergic contact hypersensit ivity reactions 
after primary sensit ization. It has been suggested that t he 
LC/IC might be target cells in the efferent limb of the immune 
response [25-27]. The presence of cytotoxic/suppressor cells in 
areas of keratinocyte alterations and LC/IC redistribut ion in 
erythema mult ifo rme as well as in P LEVA, allograft rejection , 
and allergic contact hypersensitivity reactions suggest t hat 
these alte rations may result from sensit ized lymphocytes either 
by direct cytotoxicity or by t he release of lymphokines 
[22, 25,t ]. 
P revious studies using 1-J.Lm Giemsa-stained sections [1] as 
well as findings in the present study, suggest that a lymphocyte-
dependent effector pathway plays a predominant role in ery-
t hema mult iforme and t hat t he immune complexes may have a 
different fu nction from t hose complexes that are operative in 
complement-fixing, immune complex-mediated disorders. In 
vitro tests that support a role fo r a ce ll-mediated immune 
response in t he pathogenesis of erythema multiforme include 
lymphocyte transformation and the production of macrophage 
migratory inhibitory factor when autologous lymphocytes are 
cultured with an ant igen such as a sensitizing drug a llergen 
[28,29]. Further, there is evidence suggesting that experimen-
tally induced cell -mediated reactions in t he glomeruli of rats 
can be induced aga inst ant igens in immune complexes located 
in t he glomerul i [30,31]. Thus, in erythema mult iforme t he 
immune complexes or components t hereof may serve as an 
ant igen t hat induces cell -mediated responses. Perhaps the LC/ 
IC, which are capal; le of present ing antigen to lymphocyt es, 
become targets of the lymphocyte-mediated immune response. 
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